Regulation of genes involved in fatty acid (FA) utilization in heart and liver of weanling rats was investigated in response to variations in dietary lipid content and to changes in intracellular FA homeostasis induced by etomoxir, a blocker of FA import into mitochondria. Northern-blot analyses were performed using cDNA probes specific for FA transport protein, a cell membrane FA transporter; long-chain-and medium-chain acyl-CoA dehydrogenases, which catalyze the first step of mitochondrial FA ␤-oxidation; and acyl-CoA oxidase, a peroxisomal FA ␤-oxidation marker. High-fat feeding from postnatal d 21 to 28 resulted in a coordinate increase (58 to 136%) in mRNA abundance of all genes in heart. In liver, diet-induced changes in mitochondrial and peroxisomal ␤-oxidation enzyme mRNAs (from 52 to 79%) occurred with no change in FA transport protein gene expression. In both tissues, the increases in mRNA levels went together with parallel increases in enzyme activity. Changes in FA homeostasis resulting from etomoxir administration led to a marked stimulation (76 to 180%) in cardiac expression of all genes together with parallel increases in enzyme activities. In the liver, in contrast, etomoxir stimulated the expression of acyl-CoA oxidase gene only. Feeding rats a low-fat diet containing 0.5% clofibrate, a ligand of peroxisome proliferator-activated receptor ␣, resulted in similar inductions of ␤-oxidation enzyme genes in both tissues, whereas up-regulation of FA transport protein gene was restricted to heart. Altogether, these data suggest that changes in FA homeostasis in immature organs resulting either from highfat diet or ␤-oxidation blockade can efficiently be transduced to the level of gene expression, resulting in tissue-specific adaptations in various FA-using enzymes and proteins. Fatty acids are the main energy substrates supplied to developing mammals in maternal milk (1) , and the importance of fatty acids in energy metabolism during this period is underscored by the severe clinical manifestations of inborn deficits in ␤-oxidation enzymes (2) . Besides their role in energy metabolism, fatty acids might act as regulators of gene expression for enzymes and proteins involved in their own utilization, as consistently suggested by recent in vitro molecular data (3) (4) (5) (6) . In fact, fatty acids can bind and activate PPAR␣, a member of the steroid-thyroid hormone receptor superfamily (7), leading to transactivation of genes involved in the various fatty acid oxidation pathways (8) . However, there are as yet little data regarding the physiologic relevance of these regulatory mechanisms.
The objective of the present study was therefore to determine whether changes in whole body lipid balance performed in weanling rats could affect the expression levels of several genes encoding protein and enzymes involved in the transport and ␤-oxidation of fatty acids, in the immature heart and liver. FATP is an integral plasma membrane protein originally shown to increase cellular fatty acid uptake in adipocytes (9) . The LCAD and MCAD genes encode enzymes that catalyze the initial step of mitochondrial fatty acid ␤-oxidation, with distinct carbon chain length specificities. Finally, the ACO gene, which encodes the first enzyme of peroxisomal fatty acid ␤-oxidation, is admitted to reflect the expression level of peroxisomal fatty acid catabolism (10) .
We first sought to determine whether dietary manipulations of saturated medium-and long-chain fatty acids can induce variations in the expression levels of the genes studied. To further investigate in vivo gene regulation in response to fatty acids, we studied in parallel the effects on gene expression of treating rats fed a high-fat diet with etomoxir, an inhibitor of mitochondrial CPT-1 (11), which induces intracellular build-up in long-chain fatty acids and fatty acid derivatives. Finally, mRNA studies were also performed in clofibratetreated rats.
The results obtained point out the ability of immature tissues to control gene expression of enzymes involved in various steps of cellular fatty acid metabolism as a function of fatty acid dietary intake and in response to changes in intracellular fatty acid homeostasis.
METHODS

Animals and Diets
Pregnant Wistar rats were bred and mated in our laboratory and had free access to water and standard food (UAR 113, containing, per 100 g, 51 g carbohydrate, 22 g protein, and 5 g lipid; UAR, Villemoisson-sur-Orge, France). Each litter was reduced to 10 animals at birth. Pups were kept with their mothers until d 21 after birth, and then weaned on various specific diets, from d 21 to 28. All animal experiments were performed in accordance with the INSERM guidelines for the care and use of laboratory animals.
A group of animals was kept on a low-fat diet. This diet was obtained commercially from UAR and provided, per 100 g, 58 g carbohydrate, 19 g protein, and Ͻ 1 g residual lipids; under this diet, lipids account for Ͻ 3% of the total caloric supply. A second group of animals was fed a high-fat diet, which was prepared by adding 25% coconut oil (Sigma Chemical Co., St. Louis, MO, U.S.A.) to the low-fat food, and provided, per 100 g, 41 g carbohydrate, 14 g protein, and 25 g lipid. Accordingly, lipids accounted for 55% of the caloric supply in the high-fat diet. For the metabolic inhibitor studies, the rats were fed the high-fat diet and received a daily i.p. injection of etomoxir (40 mg/kg body weight). Another group of rat pups was fed the low-fat diet supplemented with 0.5% (wt/wt) clofibrate, a PPAR␣ ligand (7) . A final group of animals was kept on the low-fat diet and received a daily injection of glucagon (2 g/100 g body weight) from d 21 to 28. Food intake in the various groups of animals was determined daily by weighing the amount of food consumed, and body weight measurements were performed in parallel.
On d 28, the heart and liver were removed under ketamine anesthesia (100 mg/kg body weight; Imalgène, Rhô neMérieux, Lyon, France). The tissues were immediately frozen in liquid nitrogen, and stored at -80°C. Blood samples were always collected at 0930 h, from axillary artery, in heparinized glass tubes and immediately centrifuged. Plasma samples were kept at -80°C until analysis. NEFA plasma levels were determined using the NEFA C WAKO kit (Dardilly, France).
Northern Blot Analysis
Total RNA was extracted in parallel from heart and liver in each animal. Electrophoresis through a formaldehydecontaining agarose gel (15 g of RNA/lane) and transfer to nylon membrane followed by UV cross-linking were performed as previously described (12) . Each membrane included a selection of mRNA samples from heart or liver under all the experimental conditions tested. Importantly, the membranes corresponding to the two tissues were always probed in parallel and successively with the various cDNAs labeled with [␣-32 P]dCTP using the random primer technique. The mitochondrial enzyme cDNA probes used in this study were rat MCAD EcoRI fragment of 871 bp (13) and rat LCAD EcoRI fragment of 1200 bp (14) . A 559-bp ACO cDNA (15) and a 717-bp cDNA comprising part of the D and E domains of the rat PPAR␣ (16) were obtained by reverse transcription coupled to PCR as described elsewhere (17) . For FATP, the hybridization was performed with the 1.3-kb BamH1-BglII fragment of mouse cDNA (9) .
Prehybridization and hybridization were performed in a hybridization oven at 68°C, using the QuickHyb solution (Stratagene Europe, Netherlands) following the manufacturer's instructions. The membranes were washed twice with 2 ϫ SSC (1 ϫ SSC is 0.15 M NaCl, 0.015 M sodium citrate) for 10 min at room temperature, once with 2 ϫ SSC and 1% SDS for 10 min at room temperature, and once with 1 ϫ SSC and 1% SDS for 10 to 15 min at 60°C. Signal density for each mRNA was quantified by computerized densitometric analysis of the autoradiograms. Finally and after the membrane were successively probed with the various cDNAs, the blots were hybridized with an 18-S cDNA probe to correct variations in the amount of RNA loaded.
Measurement of Enzyme Activity
LCAD and MCAD activity. LCAD and MCAD enzyme activities were determined spectrophotometrically at 37°C by following the decrease in ferricenium ion absorbance at 300 nm as previously described (12, 18) . Briefly, tissue samples (30 -70 mg) were weighed frozen, and the homogenates were immediately prepared as a 20% (wt/vol) suspension in ice-cold 100 mM HEPES, pH 7.6, and 0.1 mM EDTA with a motordriven Teflon/glass homogenizer. The homogenates were then centrifuged. For enzyme assay, 5 L of supernatant was added to 500 L of reaction mixture containing 100 mM HEPES, pH 
M sucrose, as described above. At 10 min of the reaction, aliquots of 50 L were taken and mixed with 1.5 mL of water, and the resulting fluorescence was read at an excitation wavelength of 315 nm and an emission wavelength of 420 nm.
After correction for fluorescence of a blank incubated without substrate and calibration with a reference solution of H 2 O 2 , the fluorescence was converted into nanomoles of H 2 O 2 produced per minute per gram wet weight.
Expression of Results and Statistical Analysis
mRNA abundance is expressed on a relative percentage basis. The data are expressed as mean Ϯ SEM. The means from five rats in each experimental group were subjected to one-way ANOVA and Fisher's exact test; p Ͻ 0.05 was considered significant.
RESULTS
The values of growth, food and energy intake, lipid consumption, and NEFA plasma levels in the various groups of animals are presented in Table 1 . Pups exhibited less appetite for high-fat than for low-fat food, as reflected by the food intake values. However, inasmuch as the caloric content per gram of high-fat food (4 kcal/g) was higher than that of low-fat food (2.2 kcal/g), the daily energy intakes were not significantly different under the various diets tested. Body growth rates appeared slightly lower under high-fat compared with low-fat diets; however, none of the differences in growth rates among the various groups reached statistical significance. Treatment by etomoxir did not result in changes in any of the variables measured, showing that etomoxir did not alter growth or nutritional status of the pups. As expected, treatment by clofibrate led to significantly lower circulating fatty acid levels. Altogether, feeding rats a high-fat diet resulted in a pronounced 
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LIPIDS CONTROL FATTY ACID ENZYME GENES increase in dietary lipid intake and in fatty acid plasma levels, compared with low-fat fed rats.
Adaptive changes in gene expression and enzyme activity in response to a high-fat diet. Figure 1 shows that weanling rats fed on diets varying by their fat content resulted in significant changes in cardiac and hepatic gene expression patterns of fatty acid metabolism enzymes. In response to high-fat diet, FATP gene expression was increased (63%) in the heart and was not affected in the liver. In contrast, heart and liver exhibited a coordinate up-regulation of all ␤-oxidation enzyme genes in response to a high-fat diet, the increases in mRNA levels ranging from 50% for MCAD to 136% for LCAD. The increases in mRNA levels paralleled increases in mitochondrial and peroxisomal enzyme activities in heart (20%) and in liver (from 27 to 123%) in response to high-fat diet (Table 2 ). ACO enzyme activity was undetectable in hearts of animals fed a low-fat diet and become measurable in rats fed a high-fat diet. To investigate a possible role of glucagon in mediating changes in gene expression in response to dietary factors, MCAD mRNA abundance was determined in rats fed a low-fat diet and receiving long-term treatment by glucagon for the d 21 to 28 period. As shown in Figure 2 , cardiac and 
Table 2. Effect of dietary lipids on LCAD, MCAD, and ACO enzyme activities in heart and liver of 28-d-old-rats
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hepatic MCAD mRNA steady-state levels were found to be unchanged in glucagon-treated pups, compared with vehicletreated rats. Effects of etomoxir in rats fed a high-fat diet. The effects of etomoxir given to rats fed a high-fat diet on mitochondrial and peroxisomal ␤-oxidation gene expression are shown in Figure  3 . Taking the values obtained in untreated rats fed a high-fat diet as reference, ACO mRNA levels were increased by 100% and 250% in heart and liver, respectively. The FATP gene expression was stimulated in heart but not in liver, as observed in response to high-fat feeding. Finally, MCAD gene expression was significantly raised in heart but not in liver. Changes in MCAD and ACO mRNA were accompanied by parallel increases in enzyme activities ( Table 3) .
Effects of clofibrate on heart and liver gene expression. The results obtained from heart and liver of rats weaned on low-fat food containing 0.5% clofibrate are presented in Figure  4 . Clofibrate resulted in a general increase in heart mRNA levels of all genes, ranging from 2.3-fold for FATP, up to 3.5-fold in the case of LCAD. Liver LCAD, MCAD, and ACO genes were also markedly induced (3 to 7 times) in response to clofibrate. In contrast to heart, liver FATP gene expression was unaffected by clofibrate administration.
Effects of various treatments on PPAR␣ gene expression. In both tissues, feeding rats high-fat, etomoxir-or clofibratecontaining diets did not significantly change PPAR␣ mRNA steady-state levels (Fig. 5 ).
DISCUSSION
Recent in vitro studies suggest that fatty acids might act as transcriptional regulators for a variety of genes encoding enzymes and proteins involved in lipid metabolism (3) (4) (5) (6) , but there are as yet little data to assess the significance of these regulatory mechanisms in vivo. The dietary manipulations performed in this study allowed us to induce large variations in the amount of saturated fat consumed by weanling rats for a 1-wk period. Our results demonstrate that the genes encoding FATP, LCAD, MCAD, and ACO are all putative targets for adaptive changes in response to dietary fat manipulations. The expressions of all genes were coordinately up-regulated in response to a high-fat diet in heart. In liver, high-fat feeding resulted in induced expression of all ␤-oxidation enzyme genes, but did not affect FATP mRNA levels. Changes in gene expression in rats fed a high-fat diet might result from hormonal factors and, in particular, from the rise in circulating glucagon, which results from the high lipid intake. However, long-term administration of glucagon to pups aged 21 to 28 d failed to induce changes in heart or liver MCAD gene expression, clearly suggesting that glucagon does not play a major role in mediating dietary-induced changes in gene expression observed in the present study.
Altogether, the mitochondrial and peroxisomal fatty acid ␤-oxidation pathways therefore appear as major targets for nutritional gene regulation in both tissues studied, whereas changes in dietary fat supply can also induce tissue-specific regulation of FATP gene expression.
These responses to a high-fat diet led us to investigate the gene expression patterns in immature tissues challenged by 695 additional perturbations in lipid homeostasis. To address this question, we studied FATP, MCAD, and ACO mRNA levels in rats fed a high-fat diet and chronically treated by etomoxir. Inhibition by etomoxir of long-chain fatty acid import into the mitochondria leads to increased cellular levels of fatty acid and their derivatives, and therefore induces major changes in intracellular fatty acid homeostasis (11) . Etomoxir administration resulted in a coordinate induction of all genes in heart with lower effects in liver. Previous results obtained from PPAR␣ knockout mice receiving etomoxir demonstrated that PPAR␣ plays a cardinal role in transducing changes in fatty acid homeostasis to the level of gene expression (20) . Our data obtained from heart and liver of etomoxir-treated rats therefore suggest that PPAR␣ could stimulate the expression of the genes studied in response to changes in intracellular fatty acid homeostasis. To evaluate the capacity of PPAR␣ to mediate changes in gene expression, we analyzed cardiac and hepatic mRNA levels in l rats fed a low-fat diet and receiving clofibrate, a PPAR␣ ligand. In fact, the four genes considered in this study were all found to be induced by clofibrate. It is noteworthy that FATP gene regulation in response to clofibrate was strictly restricted to heart, consistent with the results obtained from rats fed a high-fat fed diet or also treated with etomoxir. Studies run in adult rats already suggested that stimulation of FATP gene expression by peroxisome proliferators, could occur in a tissue-specific manner (21) . Both developing heart and liver expressed significant levels of PPAR␣ mRNA, and none of the treatments performed in this study led to changes in the steady-state levels of PPAR␣.
Altogether, the present in vivo results indicate that the PPAR␣ gene regulation pathway is active in the immature heart and liver of weanling rats. These results also demonstrate that fatty acids can exert an in vivo autoregulatory and coordinate effect over gene expression, which can target not only peroxisomal or mitochondrial ␤-oxidation enzymes but also a protein involved in fatty acid transport.
